What’s the flu season in Australia got to do with sales of winter remedies in the UK? Quite a lot, apparently, as the ...

“Almost all the nasal sprays, like nasal antihistamine sprays, they all work and they are also over-the-counter, but they don’t say ‘decongestant.’” In addition to steroid nasal sprays ...

The best over-ear headphones completely immerse you in sound. It's no secret that by design, they're more tuned for audiophiles, who often favor wired models where there’s more room for large ...

No device is a perfect fit for everyone, and particularly for older adults, operating hearing aids might be complicated. To help you in your search, we’ve created this audiologist-approved list of the ...

The device is geared toward adults 18 years and older with type ... was cleared by the U.S. Food and Drug Administration for over-the-counter use in March — is a wearable device that fits ...

CEO Corie Barry said the company saw encouraging growth in the sales of tablets and computers in the quarter, though comparable store sales declined more than 2% year over year. Best Buy updated ...

as French health chiefs urge public not to use ANOTHER decongestant over fears it could cause strokes ... which are relatively harmless to adults and older children, might markedly affect infants ...

All three funds are up more than 25% over the past year and have averaged between an 18% and 22% annual return over the last five years and a 16% to 20% annual return over the last decade.

Aug 26 (Reuters) - Dexcom (DXCM.O), opens new tab said on Monday its over-the-counter continuous glucose ... U.S. health regulator in March for use by adults aged 18 and older who do not use ...

Other days, I wonder if I should call my doctor. The Stelo is unique in that it’s one of three FDA-cleared over-the-counter CGMs. (The other two are from Abbott.) Typically, CGMs have been used ...

After getting the green light from the FDA back in March, Dexcom today launched its first over-the-counter wearable continuous ... Dexcom designed Stelo for adults 18 years and older who are ...

(NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that Stelo, the first over-the-counter glucose biosensor in the U.S., is now ...